registrieren | anmelden | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

deps dopamine [25 articles]

Neue Publikationen in deps Bibliothek eingetragen unter dem Bezeichner: dopamine. You can also see everyone's dopamine.
  • Meaningful silences: how dopamine listens to the ACh pause.
    Trends Neurosci (26 January 2006)
    by Stephanie J J Cragg
  • Dopamine cells respond to predicted events during classical conditioning: evidence for eligibility traces in the reward-learning network.
    J Neurosci, Vol. 25, No. 26. (29 June 2005), pp. 6235-6242.
    by WX Pan, R Schmidt, JR Wickens, BI Hyland
  • The relevance of iron in the pathogenesis of Parkinson's disease.
    Ann N Y Acad Sci, Vol. 1012 (March 2004), pp. 193-208.
    by ME Götz, K Double, M Gerlach, MB Youdim, P Riederer
  • The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity.
    Psychol Rev, Vol. 109, No. 4. (October 2002), pp. 679-709.
    by CB Holroyd, MG Coles
  • Neural Coding of Distinct Statistical Properties of Reward Information in Humans.
    Cereb Cortex (20 July 2005)
    by Jean-Claude C Dreher, Philip Kohn, Karen Faith F Berman
  • A Neural Substrate of Prediction and Reward
    Science, Vol. 275, No. 5306. (14 March 1997), pp. 1593-1599.
    by Wolfram Schultz, Peter Dayan, Read P Montague
  • Oxidative stress in Parkinson's disease.
    Ann Neurol, Vol. 53 Suppl 3 (2003)
    by P Jenner
    posted to dopamine iron parkinsons pathway review by dep on 2006-03-28 06:27:49 as ** along with 1 group Glimcher_Lab
  • Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.
    Neurotox Res, Vol. 5, No. 1-2. (2003), pp. 35-44.
  • Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease.
    Exp Neurol, Vol. 182, No. 2. (August 2003), pp. 483-489.
    by X Junxia, J Hong, C Wenfang, Q Ming
  • Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys.
    Free Radic Biol Med, Vol. 35, No. 5. (1 September 2003), pp. 540-547.
    by Y He, PS Thong, T Lee, SK Leong, BY Mao, F Dong, F Watt
    posted to basalganglia dopamine iron neurotoxicity by dep on 2006-03-28 06:23:59 as ** along with 1 group Glimcher_Lab
  • The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration.
    Exp Neurol, Vol. 184, No. 1. (November 2003), pp. 530-535.
    posted to dopamine neurotoxicity by dep on 2006-03-28 06:23:10 as ** along with 1 group Glimcher_Lab
  • An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury.
    Free Radic Biol Med, Vol. 36, No. 5. (1 March 2004), pp. 555-564.
    posted to dopamine neurotoxicity by dep on 2006-03-28 06:21:10 as ** along with 1 group Glimcher_Lab
  • The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
    Brain Res, Vol. 1004, No. 1-2. (9 April 2004), pp. 29-44.
    by EA Mazzio, RR Reams, KF Soliman
  • Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.
    Neurochem Int, Vol. 45, No. 1. (July 2004), pp. 103-116.
  • Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Ann N Y Acad Sci, Vol. 1012 (March 2004), pp. 306-325.
  • p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
    J Neurosci Res, Vol. 79, No. 6. (15 March 2005), pp. 849-860.
    posted to dopamine iron neurotoxicity pathway by dep on 2006-03-28 06:15:09 as ** along with 1 group Glimcher_Lab
  • Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra
    Journal of Neurochemistry, Vol. 92, No. 5. (March 2005), pp. 1021-1032.
    by Irmgard Paris, Pedro Martinez-Alvarado, Carolina Perez-Pastene, Marcelo NN Vieira, Claudio Olea-Azar, Rita Raisman-Vozari, Sergio Cardenas, Rebeca Graumann, Pablo Caviedes, Juan Segura-Aguilar
    posted to dopamine neurotoxicity pathway by dep on 2006-03-28 06:14:31 as ** along with 1 group Glimcher_Lab
  • Dopaminergic neurons.
    Int J Biochem Cell Biol, Vol. 37, No. 5. (May 2005), pp. 942-946.
    by SJ Chinta, JK Andersen
  • Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Prog Neurobiol, Vol. 75, No. 2. (February 2005), pp. 109-124.
    posted to dopamine iron parkinsons pathway review by dep on 2006-03-28 06:12:31 as ** along with 1 group Glimcher_Lab
  • Iron protects astrocytes from 6-hydroxydopamine toxicity.
    Neuropharmacology, Vol. 48, No. 5. (April 2005), pp. 720-731.
    posted to dopamine neurotoxicity pathway by dep on 2006-03-28 06:08:42 as ** along with 1 group Glimcher_Lab
  • New paradigms in the treatment of restless legs syndrome.
    Neurology, Vol. 64, No. 12 Suppl 3. (28 June 2005)
    by MJ Thorpy
    posted to dopamine iron pathology review by dep on 2006-03-28 06:03:14 as ** along with 1 group Glimcher_Lab
  • Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.
    J Neurosci, Vol. 25, No. 27. (6 July 2005), pp. 6329-6342.
    posted to dopamine parkinsons pathway by dep on 2006-03-28 06:02:08 as *** along with 1 group Glimcher_Lab
  • Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
    Brain Res Mol Brain Res, Vol. 139, No. 2. (3 October 2005), pp. 341-347.
    posted to dopamine parkinsons pathway by dep on 2006-03-28 06:00:57 as *** along with 1 group Glimcher_Lab
  • Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion
    Journal of Neurochemistry, Vol. 95, No. 1. (October 2005), pp. 79-88.
    by Shunit Gal, Hailin Zheng, Mati Fridkin, Moussa B Youdim
    posted to dopamine pathway by dep on 2006-03-28 05:59:42 as ** along with 1 group Glimcher_Lab
  • Iron accelerates the conversion of dopamine-oxidized intermediates into melanin and provides protection in SH-SY5Y cells.
    J Neurosci Res, Vol. 82, No. 1. (1 October 2005), pp. 126-137.
    posted to dopamine parkinsons by dep on 2006-03-28 05:58:33 as *** along with 1 group Glimcher_Lab
  • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/user/dep/tag/dopamine

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.